Consensus DexCom, Inc. Xetra

Stocks

DC4

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Xetra 16:35:36 02/10/2026 BST			After hours 20:17:16
76.40 ^EUR	-0.52%		75.70	-0.92%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

bcf87a89.B4NRry3DO7gRlDIDRpBLFSYSWU_ikCuINhXTFrTDSro.QMAC4UWrC-t00ks1Auguf2FCIB2WpGTEUXqqINm1AdlYygDmFLNqyX6sXQ~60b0b7aca30002be0abf5c51f449a7df

Analysts' recommendations: DexCom, Inc.

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
07-31	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+24.38%
	MEDTRONIC PLC					+21.28%
	STRYKER CORPORATION					+34.74%
	ESSILORLUXOTTICA					+60.86%
	CENCORA, INC.					+19.2%
	HOYA CORPORATION					+23.82%
	BECTON, DICKINSON AND COMPANY					+9.88%
	IDEXX LABORATORIES, INC.					+35.46%
	DEXCOM, INC.					+10.26%
	Average					+26.65%
	Weighted average by Cap.					+27.90%